Возраст домена | 25 лет |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | 0 |
Страниц в Google | 926 |
Страниц в Яндексе | 178 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 590153 |
Alexa Country | 205340 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
AstraZeneca US
n/a
n/a
UTF-8
160.15 КБ
2 500
22 050 симв.
18 523 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
astrazeneca.com | 176 | 7 |
170 | 55173 | 29098 | |
purplepill.com | 101 | 4 |
0 | 1281706 | 326587 | |
pinkforoctober.org | 78 | 6 |
0 | Нет данных | Нет данных | |
seroquelxr.com | 77 | 4 |
0 | 4889031 | Нет данных | |
carecyclesolutions.net | 73 | 3 |
0 | 11869033 | Нет данных | |
mysymbicort.com | 68 | 4 |
0 | 584619 | 148505 | |
crestor.com | 61 | 4 |
0 | 1299750 | 466142 | |
seroquelxrtouchpoints.com | 53 | 4 |
0 | 11259946 | Нет данных | |
symbicorttouchpoints.com | 52 | 4 |
0 | 1793462 | 463394 | |
nexiumtouchpoints.com | 46 | 4 |
0 | 11962039 | Нет данных | |
wikipedia.org | 7 | 9 |
0 | 5 | 6 | |
drugs.com | 7 | 7 |
0 | 3848 | 1398 | |
rxlist.com | 6 | 7 |
0 | 7347 | 1874 | |
crestortouchpoints.com | 6 | 4 |
0 | 3812115 | 652993 | |
medicines.org.uk | 5 | 6 |
50 | 21875 | 1897 | |
medicinenet.com | 4 | 7 |
0 | 4097 | 1342 | |
drugwatch.com | 4 | 6 |
10 | 269516 | 203147 | |
goodrx.com | 3 | 5 |
20 | 14041 | 2419 | |
emedicinehealth.com | 3 | 7 |
0 | 28996 | 7981 | |
Еще 31 сайт после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 9 Ноября 2016 ) | |
Количество ссылок на сайт | 23661 |
Количество доменов, которые ссылаются на сайт | 695 |
Количество найденных анкоров | 288 |
Исходящие (внешние) ссылки домена | 0 |
Количество доменов, на которые ссылается сайт | 0 |
Количество исходящих анкоров | 0 |
Внешние ссылки главной страницы ( 16 ) | |
us-cookienotice.astrazeneca.com/ | cookie notice. |
astrazeneca.com/global/en/AstraZeneca-Websites.html | AstraZeneca Websites |
astrazeneca.com/ | Global site |
twitter.com/AstraZenecaUS | |
twitter.com/intent/tweet?in_reply_to=1203072842771943429 | reply |
twitter.com/intent/retweet?tweet_id=1203072842771943429 | 7 |
twitter.com/intent/favorite?tweet_id=1203072842771943429 | 0 |
twitter.com/intent/tweet?in_reply_to=1203037831226105857 | reply |
twitter.com/intent/retweet?tweet_id=1203037831226105857 | 2 |
twitter.com/intent/favorite?tweet_id=1203037831226105857 | 5 |
twitter.com/intent/tweet?in_reply_to=1202989584927191040 | reply |
twitter.com/intent/retweet?tweet_id=1202989584927191040 | 1 |
twitter.com/intent/favorite?tweet_id=1202989584927191040 | 1 |
twitter.com/astrazenecaus | Follow AstraZenecaUS |
astrazeneca.com/what-science-can-do.html | Explore more on on our global site |
facebook.com/AstraZenecaUSCommunityConnections/ | |
Внутренние ссылки главной страницы ( 115 ) | |
#! | ? |
/az-in-us.html | AstraZeneca in the US |
/az-in-us/Contact-us.html | Contact us |
/sustainability.html | Sustainability |
/sustainability/patient-programs.html | Patient programs |
/sustainability/Improving-access-to-care.html | Improving access to care |
/sustainability/health-and-science-innovation.html | Health and science innovation |
/sustainability/employee-volunteerism-giving.html | Employee Volunteerism and Giving |
/sustainability/Request-Support.html | Community support |
/sustainability/healthcare-foundation.html | AstraZeneca HealthCare Foundation |
/sustainability/Responsible-business.html | Responsible business |
/sustainability/Corporate-transparency.html | Corporate transparency |
/medicines.html | Medicines |
/medicines/astrazeneca-medications.html | Medicines |
/medicines/Affordability.html | Affordability |
/medicines/astrazeneca-direct.html | AstraZeneca Direct |
/medicines/product-counterfeiting.html | Product counterfeiting |
medicalinformation.astrazeneca-us.com/home.html | Medical information for healthcare providers |
/careers.html | Careers |
/careers/military-careers.html | Military careers |
/media.html | Media |
/media/astrazeneca-us-blog.html | AZ&You Blog |
/media/press-releases/2019/imfinzi-durvalumab-granted-fda-pr... | IMFINZI® (durvalumab) granted FDA priority review for the treatment of patients with extensive-stage small cell lung cancer As... |
/media/press-releases/2019/calquence-approved-in%20the-us-fo... | CALQUENCE approved in the US for adult patients with chronic lymphocytic leukemia Two Phase III CALQUENCE trials demonstrated ... |
/media/press-releases/2019/subgroup-analysis-of-twilight-tri... | Subgroup analysis of TWILIGHT trial patients with non-ST elevation acute coronary syndrome (NSTE-ACS) who underwent PCI showed B... |
/media/press-releases/2019/consistent-effects-of-farxiga-in-... | Consistent effects of FARXIGA in heart failure patients with reduced ejection fraction shown in new analyses from landmark Phase... |
/media/astrazeneca-us-blog/2019/project-seed-supporting-a-dy... | Project SEED: Supporting a Dynamic STEM Education Experience 18 June 2019 |
/media/astrazeneca-us-blog/2019/understanding-the-unexpected... | Understanding the Unexpected Connections between Diabetes and Kidney Disease 5 June 2019 |
/media/astrazeneca-us-blog/2019/bob-harper-and-astrazeneca-t... | Bob Harper and AstraZeneca Take Survivors Have Heart on the Road 3 June 2019 |
/media/astrazeneca-us-blog/2019/survivors-have-heart-one-yea... | Survivors Have Heart One Year Later and Beyond 28 February 2019 |
/media/astrazeneca-us-blog/2019/the-path-forward-evolving-th... | The Path Forward, Evolving the Current Healthcare System 28 February 2019 |
/media/astrazeneca-us-blog/2019/important-discoveries-in-ast... | Important Discoveries in Asthma 22 February 2019 |
/media/astrazeneca-us-blog/2019/nonprofits-innovate-to-solve... | Nonprofits Innovate to Solve Health Challenges and STEM Shortages 12 February 2019 |
/media/astrazeneca-us-blog/2019/employees-lead-the-way-throu... | Employees Lead the Way through Volunteerism and Giving 17 January 2019 |
/media/astrazeneca-us-blog/2019/the-critical-need-for-unders... | The Critical Need for Understanding the Complexities of Chronic Kidney Disease 11 January 2019 |
/media/astrazeneca-us-blog/2018/metastatic-egfrm-non-small-c... | Metastatic EGFRm+ Non-Small Cell Lung Cancer in the Era of Personalized Medicine 5 December 2018 |
/media/astrazeneca-us-blog/2018/being-an-advocate-helps-me-t... | Being an Advocate Helps Me Thrive 27 November 2018 |
/media/astrazeneca-us-blog/2018/caring-for-a-loved-one-with-... | Caring for a Loved One with COPD 19 November 2018 |
/media/astrazeneca-us-blog/2018/astrazenecas-commitment-to-i... | AstraZeneca’s Commitment to Improving the Lives of Patients with Renal-Cardio Disease 26 October 2018 |
/media/astrazeneca-us-blog/2018/vanessa-lachey-on-rsv-and-pr... | Vanessa Lachey on RSV, and Protecting Your Little Ones’ Lungs This Season 22 October 2018 |
/media/astrazeneca-us-blog/2018/whats-changed-during-17-year... | What’s Changed during 17 Years with Metastatic Breast Cancer? 1 October 2018 |
/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-... | Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know 24 September 2018 |
/media/astrazeneca-us-blog/2018/7th-annual-womens-summit-cha... | 7th Annual Women’s Summit Challenges Employees to Believe, Lead, Change 18 September 2018 |
/media/astrazeneca-us-blog/2018/3-ways-were-supporting-the-b... | 3 Ways We’re Supporting the Blood Cancer Community 31 August 2018 |
/media/astrazeneca-us-blog/2018/highlights-from-our-inclusio... | Highlights from our Inclusion & Diversity Conference 31 July 2018 |
/media/astrazeneca-us-blog/2018/this-is-the-future-immuno-on... | This is the Future: Immuno-Oncology is Redefining Cancer Treatment 17 July 2018 |
/media/astrazeneca-us-blog/2018/celebrating-inclusion-and-di... | Celebrating Inclusion and Diversity during LGBTQA Pride Month 5 June 2018 |
/media/astrazeneca-us-blog/2018/4-big-ways-employees-gave-ba... | 4 Big Ways Employees Gave Back during “Power of Us Week” 31 May 2018 |
/media/astrazeneca-us-blog/2018/5-ways-were-fighting-cancer-... | 5 Ways We’re Fighting Cancer in the US 29 May 2018 |
/media/astrazeneca-us-blog/2018/what-were-watching-during-as... | What We’re Watching During ASCO 2018 29 May 2018 |
/media/astrazeneca-us-blog/2018/reducing-the-burden-of-diabe... | Reducing the Burden of Diabetes: 3 Takeaways from the ADA’s Recent Report 21 May 2018 |
/media/astrazeneca-us-blog/2018/patient-advocacy-leader-shar... | Patient Advocacy Leader Shares Advice for People Living with Bladder Cancer 3 May 2018 |
/media/astrazeneca-us-blog/2018/making-some-sense-of-lung-ca... | Making Some Sense of Lung Cancer 18 April 2018 |
/media/astrazeneca-us-blog/2018/lung-cancer-treatment-today-... | Lung Cancer Treatment Today: Earlier and More Precise 13 April 2018 |
/media/astrazeneca-us-blog/2018/bob-harper-on-connecting-wit... | Bob Harper on Connecting with Fellow Heart Attack Survivors 6 April 2018 |
/media/astrazeneca-us-blog/2018/meet-the-survivors-have-hear... | Meet the Survivors Have Heart Essay Contest Winners 1 March 2018 |
/media/astrazeneca-us-blog/2018/heres-what-metastatic-breast... | Here’s What Metastatic Breast Cancer Patients Want You to Know 22 February 2018 |
/media/astrazeneca-us-blog/2018/a-years-worth-of-giving-our-... | A Year’s Worth of Giving: Our 2017 Power of Us Impact 22 January 2018 |
/media/astrazeneca-us-blog/2018/community-programs-help-impr... | Community Programs Help Improve Heart Health and Share Lessons Learned 18 January 2018 |
/media/astrazeneca-us-blog/2018/moving-forward-as-a-heart-at... | Moving Forward as a Heart Attack Survivor 16 January 2018 |
/media/astrazeneca-us-blog/2017/employees-give-back-to-those... | Employees Give Back to those Affected by Natural Disasters in 2017 19 December 2017 |
/media/astrazeneca-us-blog/2017/stories-of-hope-from-people-... | Stories of Hope from People with Lymphoma 4 December 2017 |
/media/astrazeneca-us-blog/2017/advancing-stem-through-the-h... | Advancing STEM through the Health & Science Innovation Challenge 28 November 2017 |
/media/astrazeneca-us-blog/2017/more-than-a-tagline-deliveri... | More than a Tagline: Delivering Value to Patients 14 November 2017 |
/media/astrazeneca-us-blog/2017/understanding-if-your-asthma... | Understanding if Your Asthma is Severe 20 November 2017 |
/media/astrazeneca-us-blog/2017/from-scanxiety-to-living-lif... | From ‘Scanxiety’ to Living Life Fully: Robert’s Stage III Lung Cancer Story 10 November 2017 |
/media/astrazeneca-us-blog/2017/why-were-talking-about-cvmd-... | Why We’re Talking about CVMD 9 November 2017 |
/media/astrazeneca-us-blog/2017/a-mothers-strategy-to-protec... | A Mother’s Strategy to Protect Against RSV 4 October 2017 |
/media/astrazeneca-us-blog/2017/living-with-metastatic-breas... | Living with Metastatic Breast Cancer: Swimmer Raises Awareness and Research Funding 2 October 2017 |
/media/astrazeneca-us-blog/2017/5-important-things-to-know-a... | 5 Important Things to Know About Lung Cancer 7 September 2017 |
/media/astrazeneca-us-blog/2017/expanding-treatment-options-... | Expanding Treatment Options to Address Unmet Need in Blood Cancer 5 September 2017 |
/media/astrazeneca-us-blog/2017/employees-donate-their-time-... | Employees Donate their Time to Support Communities during Power of Us Week 20 June 2017 |
/media/astrazeneca-us-blog/2017/personalizing-lung-cancer-wh... | Personalizing Lung Cancer: Why Testing Matters 3 June 2017 |
/media/astrazeneca-us-blog/2017/making-science-understandabl... | Making Science Understandable and Accessible for Cancer Patients 30 May 2017 |
/media/astrazeneca-us-blog/2017/how-the-chest-foundation-is-... | How the CHEST Foundation is Addressing the Needs of Severe Asthma Patients 19 May 2017 |
/media/astrazeneca-us-blog/2017/more-than-4-million-patients... | More than 4.5 Million Patients Assisted over Ten Years 15 May 2017 |
/media/astrazeneca-us-blog/2017/knowing-your-options-when-fa... | Knowing Your Options When Facing Advanced Bladder Cancer 1 May 2017 |
/media/astrazeneca-us-blog/2017/advancing-science-and-accele... | Advancing Science and Accelerating Innovation in the BioHealth Capital Region 27 April 2017 |
/media/astrazeneca-us-blog/2017/supporting-patients-and-comm... | Supporting Patients and Communities: Our 2016 Corporate Responsibility at a Glance 21 April 2017 |
/media/astrazeneca-us-blog/2017/a-new-approach-to-reducing-l... | A New Approach to Reducing Lung Cancer Deaths and Extending Lives 23 March 2017 |
/media/astrazeneca-us-blog/2017/the-power-of-us-employees-co... | The Power of Us: Employees’ Community Impact in 2016 6 January 2017 |
/media/astrazeneca-us-blog/2016/our-favorites-from-2016-high... | Our Favorites from 2016 – Highlights of the AZ&You Blog Throughout 2016 on our blog, we shared interviews with patients; news ... |
/media/astrazeneca-us-blog/2016/stigma-genetics-and-hope-11-... | Stigma, Genetics and Hope: 11 Years with Lung Cancer In 2005, Melissa Crouse was diagnosed with lung cancer and given three to... |
/media/astrazeneca-us-blog/2016/what-does-the-new-cancerlinq... | What Does the New CancerLinQ Discovery Initiative Mean for the Future of Patient Care? By Kevin Fitzpatrick, CEO, CancerLinQ ... |
/media/astrazeneca-us-blog/2016/personalized-healthcare-what... | Personalized Healthcare: What It Means and Why It Matters When it comes to cancer treatment, one size does not fit all. Of the... |
/media/astrazeneca-us-blog/2016/what-getting-on-it-means-to-... | What Getting ON IT Means to Me for American Diabetes Month® By Dr. Phil McGraw As someone who has lived with type 2 diabetes f... |
/media/astrazeneca-us-blog/2016/how-the-type-2-diabetes-pati... | How the Type 2 Diabetes Patient Community is Unifying their Voice Online While online conversations about diabetes are on the ... |
/media/astrazeneca-us-blog/2016/astrazeneca-gives-back-advan... | AstraZeneca Gives Back: Advancing Respiratory Health Beyond the Medicine “Before being diagnosed with COPD, I lived a dramatic... |
/media/astrazeneca-us-blog/2016/protecting-your-childs-lungs... | Protecting Your Child’s Lungs this RSV Season As seasonal viruses begin to circulate this autumn, there is no better time to ... |
/media/astrazeneca-us-blog/2016/navigating-cancer-clinical-t... | Navigating Cancer Clinical Trials: Where to Start When patients are diagnosed with cancer, the following questions may be top... |
/media/astrazeneca-us-blog/2016/one-brave-idea-75-million-re... | One Brave Idea $75 Million Research Award for Coronary Heart Disease Winner Announced AstraZeneca, the American Heart Associat... |
/media/astrazeneca-us-blog/2016/18-years-strong-living-with-... | 18 Years Strong: Living with Metastatic Breast Cancer When doctors diagnosed Kristin Johnson St. Goddard with metastatic breas... |
/media/astrazeneca-us-blog/2016/new-resource-offers-24-7-sup... | New Resource Offers 24/7 Support for those with Mental Illness Nine years ago, Danei Edelen was established in her career as a... |
/media/astrazeneca-us-blog/2016/power-of-diversity-celebrate... | The Power of Diversity Celebrated at AstraZeneca’s 5th Annual Women’s Summit “Leadership is surrounding yourself with others w... |
/media/astrazeneca-us-blog/2016/connecting-the-dots-of-hered... | Connecting the Dots of Hereditary Cancer By Sue Friedman, DVM, founder and Executive Director, Facing Our Risk of Cancer Empo... |
/media/astrazeneca-us-blog/2016/Making-Medicine-Personal-in-... | Making Medicine Personal in Cancer Treatments Cancer is one of mankind’s greatest scientific and health challenges. Today, nea... |
/media/astrazeneca-us-blog/2016/interactive-teaching-model-e... | Interactive Teaching Model Engages Students in STEM Not long ago, Emma Waldman was a fifth grader just outside of Boston, Mass... |
/media/astrazeneca-us-blog/2016/making-medicine-personal-in-... | Making Medicine Personal in Cardiovascular and Metabolic Health Cardiovascular and metabolic diseases are complex and require ... |
/media/astrazeneca-us-blog/2016/mobile-savings-and-support-a... | Mobile Savings and Support App Offers Patients New Ways to Manage Health When managing your health, convenience is key. We all... |
/media/astrazeneca-us-blog/2016/Patient-influencers-bring-me... | Patient influencers bring medical meetings to life online We recently took a look at how social media has transformed medical ... |
/media/astrazeneca-us-blog/2016/harnessing-the-immune-system... | Harnessing the Immune System to Potentially Revolutionize Cancer Treatment for Patients This year alone, nearly 1.7 million ne... |
/media/astrazeneca-us-blog/2016/purposeful-collaboration-tea... | Purposeful Collaboration: Teaming Up to Increase Community Impact AstraZeneca recently hosted a number of non-profit partners ... |
/media/astrazeneca-us-blog/2016/making-medicine-personal-in-... | Making Medicine Personal in Respiratory Health Your health and that of your loved ones is one of the most important aspects of... |
/media/astrazeneca-us-blog/2016/asking-congress-to-get-on-it... | Asking Congress to Get “On It” for Diabetes By Topher Brooke, Vice President, U.S. Diabetes, AstraZeneca On May 11, AstraZenec... |
/media/astrazeneca-us-blog/2016/i-had-no-idea-that-there-wer... | “I had no idea that there were other forms of constipation” – a Patient’s OIC Story For patients with chronic pain, taking a p... |
/media/astrazeneca-us-blog/2016/science-of-novel-drug-delive... | Science of Novel Drug Delivery in Respiratory Medicine What exactly is Co-Suspension Technology? In our recent blog post, find... |
/media/astrazeneca-us-blog/2016/a-patients-perspective-durin... | A Patient’s Perspective during Oral, Head and Neck Cancer Awareness Week By Jessica Tar, patient advocate 2010 was truly a yea... |
/media/astrazeneca-us-blog/2016/why-people-with-type-2-diabe... | Why People with Type 2 Diabetes Should Start a Walking Program Today, more than 145 million adults in the United States includ... |
/media/astrazeneca-us-blog/2016/perspectives-on-cardiovascul... | Perspectives on Cardiovascular Disease: a Multi-Faceted Condition By Steven Zelenkofske, DO, Vice President, US Medical Affair... |
/media/astrazeneca-us-blog/2016/bringing-medical-meetings-to... | Bringing Medical Meetings to Everyone via Social Media Social media takes medical meetings beyond the convention center walls ... |
/privacy-notice.html | Privacy notice |
/legal-notice.html | Legal notice |
/california-supply-chains-disclosure.html | California supply chains disclosure |
/sitemap.html | Sitemap |
/copyright.html | Copyright |
Domain Name: ASTRAZENECA-US.COM
Registry Domain ID: 4796331_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
Updated Date: 2018-12-05T07:00:49Z
Creation Date: 1998-12-10T05:00:00Z
Registry Expiry Date: 2019-12-09T05:00:00Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS1.CSCDNS.NET
Name Server: DNS2.CSCDNS.NET
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-12-12T15:18:00Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
User-Agent: *
Disallow: /*content/astraz*
Disallow: /*_escaped_fragment_
Sitemap: https://www.astrazeneca-us.com/sitemap.xml
США - 208.93.170.109
WebMD
WebMD
HTTP/1.1 200 OK
Content-Type: text/html;charset=UTF-8
Content-Length: 163993
Connection: keep-alive
Date: Sat, 07 Dec 2019 12:47:13 GMT
Server: Apache
X-Frame-Options: SAMEORIGIN
Cache-Control: public,max-age=120
Accept-Ranges: bytes
X-Mod-Pagespeed: 1.11.33.4-0
Access-Control-Allow-Origin: https://policy.cookiereports.com
Cache-Control: max-age=0, no-cache
Vary: Accept-Encoding
X-Cache: Miss from cloudfront
Via: 1.1 b5a3a07d269412210ea111017ec1157f.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: IAD79-C3
X-Amz-Cf-Id: Be9NgXdVz_RARNAQBIB7Q26oga7nb5lQjqcnPTRr4LsFyEyv3jwjJw==
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"